Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Glioma × Counseling × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 23 Rectal Neoplasms 10 Colonic Neoplasms 10 Colorectal Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Neoplasms 7 Lung Neoplasms 7 Uterine Cervical Neoplasms 6 Small Cell Lung Carcinoma 6 Endometrial Neoplasms 6 Tobacco Use Disorder 5 Prostatic Neoplasms 5 Leukemia, Myeloid, Acute 5 Depression 5 Pancreatic Neoplasms 4 Urinary Bladder Neoplasms 3 Stomach Neoplasms 3 Sexuality 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Overweight 3 Obesity 3 Leukemia 3 Esophageal Neoplasms 3 Carcinoma, Renal Cell 3 Carcinoma, Intraductal, Noninfiltrating 3 Breast Carcinoma In Situ 3 Body Weight Changes 3 Behavior 3 Anxiety Disorders 3 Unspecified Adult Solid Tumor, Protocol Specific 2

Interventions

Temozolomide 77 Bevacizumab 45 Radiotherapy 30 Irinotecan 19 Carboplatin 17 Magnetic Resonance Spectroscopy 16 Surgical Procedures, Operative 13 Carmustine 13 Radiation 9 Nivolumab 8 Erlotinib Hydrochloride 8 Thalidomide 7 Lomustine 7 Imatinib Mesylate 7 IL13-PE38 7 Everolimus 7 Aminolevulinic Acid 7 sargramostim 6 Topotecan 6 Radiotherapy, Intensity-Modulated 6 Cyclophosphamide 6 Chemotherapy, Adjuvant 6 vandetanib 5 fluorodopa F 18 5 Vincristine 5 Surveys and Questionnaires 5 Radiosurgery 5 Filgrastim 5 Blood Specimen Collection 5 temsirolimus 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03775369 2022-05-18

Glioma and Exercising

University Hospital, Basel, Switzerland

Phase NA Completed

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡